Clinical Trial Update: Safety and Pharmacokinetic Study of Y242 in Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of Y242 in adults completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Y242

Snippet

Sponsor: Imperial College London | Conditions: Obesity | Phase 1 | Status: COMPLETED | Results posted: 2021-02-08